Navigation Links
EMBO Gold Medal 2011 awarded to Simon Boulton
Date:4/20/2011

Heidelberg, Germany, 20 April 2011 - The European Molecular Biology Organization (EMBO) today announced Simon Boulton of Cancer Research UK's London Research Institute, Clare Hall Laboratories as the winner of the 2011 EMBO Gold Medal. Awarded annually, the EMBO Gold Medal recognizes the outstanding contributions of young researchers in the molecular life sciences.

Boulton receives the award in recognition of his groundbreaking research on DNA repair mechanisms. The election committee was particularly impressed by his pioneering role in establishing the nematode worm, C. elegans, as a model system to study genome instability.

"I am delighted and honoured to receive such a prestigious award," said Boulton upon hearing the news.

Throughout his career, 38-year-old Boulton and his research team have exploited the experimental strengths of several complementary systems, including C. elegans and mouse genetics, proteomics in mammalian cells and in vitro biochemistry. Some of their most important discoveries have come from contrasting the results obtained in different systems and cellular contexts. Boulton's PhD supervisor Stephen P. Jackson described him as an "absolutely outstanding scientist" and praised his unique combination of approaches that allowed him to make seminal contributions to the field encompassing DNA repair, genome instability and cancer.

Simon Boulton's research highlights include:

  • Discovering the gene RTEL1 as an anti-recombinase that impacts on genome stability and cancer and counteracts toxic recombination, which is also required in meiosis to execute non-crossover repair.

  • Discovering the PBZ motif and establishing that ALC1 (Amplified in Liver Cancer 1) is a poly(ADP-ribose)-activated chromatin-remodelling enzyme required for DNA repair. Poly (ADP-ribosyl)ation (PAR) is a post-translational modification of proteins that play an important role in mediating protein interactions and the recruitment of specific protein targets. These results provided new insights into the mechanisms by which PAR regulates DNA repair.

  • Discovering that the Fanconi Anemia proteins FANCM and FAAP24 are required for checkpoint-kinase signalling (ATR) in response to DNA damage and establishing that DNA repair defects of Fanconi Anemia cells can be suppressed by blocking error prone repair by non-homologous end joining.

Potential opportunities for cancer treatment

These discoveries gave rise to novel therapeutic approaches. Boulton's laboratory demonstrated that cells that over-express the ALC1 enzyme are highly susceptible to eradication by the chemotherapeutic Bleomycin. Since ALC1 is amplified in over 50 percent of human liver cancers, these findings may have important implications for liver cancer treatment.

The prizewinner also showed that DNA repair defects of Fanconi Anemia cells can be suppressed by blocking non-homologous end joining (NHEJ). This observation raises the possibility that NHEJ inhibitors could be used to suppress cancer predisposition in Fanconi Anemia patients.

Career stages

The UK-born scientist started his quest to investigate mechanisms of DNA repair while studying for his PhD at the University of Cambridge from 1994-1998. He describes his first exposure to the highly competitive world-class research environment in Cambridge as "extremely influential". Boulton also recognizes that establishing his own research group at the world-renowned Cancer Research UK's London Research Institute (LRI), Clare Hall Laboratories in 2002 was a key step in his scientific career.

Boulton, while still a young researcher, has been recognized with awards from both UK and international organizations, including the Colworth Medal from the Biochemistry Society and the Eppendorf/Nature Award. He became an EMBO Young Investigator in 2007 and an EMBO Member in 2009. This year he received a Wolfson Research Merit Award from the Royal Society and an Advanced Investigator Award from the ERC.

Simon Boulton will receive the EMBO Gold Medal and an award of 10,000 euros on 12 September 2011 at The EMBO Meeting in Vienna where he will give a lecture about his research.


'/>"/>

Contact: Suzanne Beveridge
communications@embo.org
49-622-189-1108
European Molecular Biology Organization
Source:Eurekalert

Related medicine news :

1. Multiple Medalist Kristina Groves Matches Hain Celestials $5,000 Donation to Right to Play
2. PA Hypnosis Center Uses 'Smart Training' Sports Psychology for Gold Medal Success
3. PNNLs Posakony honored with AAES 2009 John Fritz Medal
4. Olympic Gold Medalist Endorses Health Enterprises AfterSwim & Swim-Fit
5. Larson, McBride named 2010 ASTRO Gold Medalists
6. UCSFs Prusiner receives Presidents National Medal of Science
7. National Medal of Science awarded to Stephen Benkovic of Penn State University
8. Earl Smith receives Prentice Medal from American Academy of Optometry
9. Top Swedish scientist professor Bertil Andersson awarded prestigious Wilhelm Exner Medal in Vienna
10. San Diego Unified School District Awarded Silent Hero Grant From got breakfast?(R) Foundation
11. $250,000 grant awarded for groundbreaking ligament and tendon repair research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , ... May 24, 2016 , ... How to Write ... Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the major ... human error will ever be totally eliminated, many human performance problems can be prevented. ...
(Date:5/24/2016)... ... May 24, 2016 , ... Loma Linda University Health (LLUH) has officially broken ... Children’s Hospital. Over 3,000 people looked on as the shovels hit the dirt at ... slidehsow. , During the program, Richard H. Hart, MD, DrPH, president, LLUH, recapped ...
(Date:5/24/2016)... ... May 24, 2016 , ... Eggsurance, ... the official relaunch of its community and education hub for women considering fertility ... is to create a safe and welcoming place for women to find cycle ...
(Date:5/24/2016)... ... May 24, 2016 , ... Tuesday, May 24, Women's Excellence in Wellness, powered ... Young Living Essential Oils, taught by Patti Dolan, RYT, a Young Living Gold ... Flow is 6:30pm - 7:15pm followed by a small intro to the Oils that ...
(Date:5/24/2016)... ... May 24, 2016 , ... In light of recent heavy flooding in Houston, ... contaminated well water throughout the Houston area. , Heavy floodwaters have led to destroyed ... to contaminants. Residents may not even be aware of the contamination of their water ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 2016 Global Paclitaxel Market 2016 ... 12 companies and the Paclitaxel analysis in this study ... industry and its players. This is the ... details the current state of the industry while providing ... applications and industry chain structure. The Paclitaxel market analysis ...
(Date:5/23/2016)... May 23, 2016 According ... Share, Development, Growth and Demand Forecast to 2022 ... Other), by Application (Drug Discovery and Development, Proteomics, ... (Pharmaceuticals, Life Science and Biotechnology, Academic and Research ... Research, the global mass spectrometry market ...
(Date:5/23/2016)... , May 23, 2016 ... for detection of multiple diseases; ,Technology to be presented ... Yissum Research Development Company of the Hebrew ... into a research agreement with Aurum Ventures MKI, the technology ... development of a new diagnostic approach for early detection ...
Breaking Medicine Technology: